Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 124805
Published online Dec 9, 2026. doi: 10.5409/wjcp.124805
Published online Dec 9, 2026. doi: 10.5409/wjcp.124805
Table 7 Primary and secondary outcomes between the studied groups, n (%)/mean ± SD
| Variable | Intervention group (n = 55) | Control group (n = 54) | P value |
| Primary outcome | |||
| Weight gain (g/day) | 18.9 ± 9.5 | 12.3 ± 6.3 | < 0.0001 |
| Days to reach full enteral feeding (days) | 15.0 ± 8.24 | 16.9 ± 8.45 | 0.250 |
| NEC incidence | 3 (5.5) | 10 (18.5) | 0.0448 |
| Secondary outcome | |||
| Sepsis incidence | 8 (14.5) | 8 (14.8) | 1.0 |
| Hospital stay (days) | 23.6 ± 8.24 | 25.7 ± 8.45 | 0.339 |
| Fate | |||
| Discharged | 47 (85.5) | 46 (85.2) | 1.0 |
| Died | 8 (14.5) | 8 (14.8) | |
- Citation: Morsi WEMA, Eskander AE, Mostafa MG, Ezz ElDin Z, Abdel Maksoud FA, Elrefaee A. Early lactase enzyme supplementation: Efficacy to promote growth and feeding tolerance in preterm infants: A randomized controlled trial. World J Clin Pediatr 2026; 15(4): 124805
- URL: https://www.wjgnet.com/2219-2808/full/v15/i4/124805.htm
- DOI: https://dx.doi.org/10.5409/wjcp.124805